BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clement P, Booth T, Borovečki F, Emblem KE, Figueiredo P, Hirschler L, Jančálek R, Keil VC, Maumet C, Özsunar Y, Pernet C, Petr J, Pinto J, Smits M, Warnert EAH. GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma. J Med Biol Eng 2020;:1-11. [PMID: 33293909 DOI: 10.1007/s40846-020-00582-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Clement P, Castellaro M, Okell TW, Thomas DL, Vandemaele P, Elgayar S, Oliver-Taylor A, Kirk T, Woods JG, Vos SB, Kuijer JPA, Achten E, van Osch MJP, Detre JA, Lu H, Alsop DC, Chappell MA, Hernandez-Garcia L, Petr J, Mutsaerts HJMM; BIDS maintainers. ASL-BIDS, the brain imaging data structure extension for arterial spin labeling. Sci Data 2022;9:543. [PMID: 36068231 DOI: 10.1038/s41597-022-01615-9] [Reference Citation Analysis]
2 Henriksen OM, Del Mar Álvarez-Torres M, Figueiredo P, Hangel G, Keil VC, Nechifor RE, Riemer F, Schmainda KM, Warnert EAH, Wiegers EC, Booth TC. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques. Front Oncol 2022;12:810263. [PMID: 35359414 DOI: 10.3389/fonc.2022.810263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Booth TC, Grzeda M, Chelliah A, Roman A, Al Busaidi A, Dragos C, Shuaib H, Luis A, Mirchandani A, Alparslan B, Mansoor N, Lavrador J, Vergani F, Ashkan K, Modat M, Ourselin S. Imaging Biomarkers of Glioblastoma Treatment Response: A Systematic Review and Meta-Analysis of Recent Machine Learning Studies. Front Oncol 2022;12:799662. [PMID: 35174084 DOI: 10.3389/fonc.2022.799662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Maffei ME. Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics. IJMS 2022;23:1339. [DOI: 10.3390/ijms23031339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
5 Smits M. Update on neuroimaging in brain tumours. Curr Opin Neurol 2021;34:497-504. [PMID: 33973902 DOI: 10.1097/WCO.0000000000000950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Booth TC, Thompson G, Bulbeck H, Boele F, Buckley C, Cardoso J, Dos Santos Canas L, Jenkinson D, Ashkan K, Kreindler J, Huskens N, Luis A, McBain C, Mills SJ, Modat M, Morley N, Murphy C, Ourselin S, Pennington M, Powell J, Summers D, Waldman AD, Watts C, Williams M, Grant R, Jenkinson MD. A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research. Front Oncol 2021;11:620070. [PMID: 33634034 DOI: 10.3389/fonc.2021.620070] [Cited by in F6Publishing: 5] [Reference Citation Analysis]